Linda C. Sandin

机构：Ilya Pharma (Sweden) · ORCID：0009-0002-6639-6514

发表论文 93 篇 · 总被引 852 次 · h-index 12

代表论文

• LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study (2024 · The Lancet Oncology · 被引 73)
• Trends in haemoglobin levels from 1968 to 2017 and association with hormonal contraceptives: observations from the population study of women in Gothenburg, Sweden (2023 · Scandinavian Journal of Primary Health Care · 被引 3)
• Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial (2026 · Clinical Cancer Research · 被引 1)
• Abstract CT235: A phase I/II clinical study of an oncolytic adenovirus expressing the immunostimulatory transgenes TMZ-CD40L and 4-1BBL in advanced solid malignancies (2023 · Cancer Research · 被引 1)
• Abstract 6663: Immunostimulatory gene therapy targeting CD40/4-1BB in combination with chemotherapy induces an inflammatory gene profile in tumors from patients with advanced disease (2023 · Cancer Research · 被引 1)
• Supplementary Table S3 from Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial (2026)